Depo Pen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Depo Pen

What is Depo Pen? A Definitive Overview

Property Description
Active ingredient Benzylpenicillin (Penicillin G) and Procaine
Form Suspension for injection (Depot preparation)
Pharmacological class Beta-Lactam antibiotic / Antibacterial agent
Route of administration Intramuscular injection
Origin Natural penicillin semisynthetic derivative

The entity known as Depo Pen is a specialized pharmaceutical preparation that delivers the active antibacterial substance Benzylpenicillin, internationally recognized as Penicillin G. This medication is classified as an antibacterial agent and belongs to the broad Beta-Lactam antibiotic class. It is utilized for providing sustained systemic action against susceptible bacteria, a usage profile widely clinically recognized for managing infections where less frequent dosing is beneficial.


What Type of Medicine is Depo Pen? (Classification and Origin)

Depo Pen is an antimicrobial drug specifically intended to eliminate bacteria through a process known as bactericidal action. Its Benzylpenicillin component disrupts the infectious organisms' ability to build and maintain their protective outer wall structure, which is vital for survival. The medicine's classification within the Beta-Lactam antibiotic group reflects its chemical structure and its reliable, targeted mechanism against the bacterial cell wall. This preparation is a mainstay in healthcare settings for ensuring continuous exposure to the antibiotic, particularly in situations where oral administration is unsuitable or impractical.


Understanding the Depot Formulation and Key Components (Composition and Form)

The definitive characteristic of Depo Pen is its depot preparation, which is a specialized suspension for injection designed for intramuscular injection. This formulation is a combination product that pairs the active agent, Benzylpenicillin, with a formulation adjunct such as Procaine. This unique design ensures a slow, gradual release of the active agent from the muscle tissue, a crucial factor that guarantees a sustained therapeutic concentration in the bloodstream over an extended period. This prolonged duration of action distinguishes it significantly from standard aqueous penicillin solutions, which typically require much more frequent dosing.

What side effects are possible with Depo Pen?

Possible Side Effects and Safety Information

The safety profile for Depo Pen (Benzylpenicillin/Procaine) is governed by the systemic risks inherent to Beta-Lactam antibiotics and the acute effects associated with the Procaine component of the injection. Regulatory documents formally classify potential reactions by frequency and the body system affected.


Official Adverse Reaction Classification

The primary documented risk is Hypersensitivity (allergic reactions), ranging from common occurrences like mild skin rashes and fever to rare but life-threatening events such as Anaphylactic Shock. Other documented serious systemic effects include Haematological disorders (e.g., Haemolytic Anaemia) and conditions affecting the Renal and Gastrointestinal systems (e.g., Pseudomembranous Colitis).

Classification Example Reactions (Regulatory-Documented)
Common Mild skin rash, Nausea, Vomiting, Diarrhoea
Rare Anaphylactic shock, Convulsions, Interstitial nephritis, Pseudomembranous colitis

Procaine-Related and Population Safety Notes

A specific, temporary safety concern is the potential for acute Procaine Toxicity reactions, which may occur immediately following injection. These can include transient neurological and psychiatric effects such as anxiety, confusion, or hallucinations, which are documented in the prescribing information.

Safety constraints also address specific populations. Patients with renal impairment have a documented increased risk of Central Nervous System (CNS) toxicity (e.g., seizures) due to reduced clearance of the active substance. Furthermore, official labeling advises observation for superinfection—the overgrowth of non-susceptible organisms—which is a known risk associated with prolonged antibiotic exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Benzylpenicillin Procaine overdosage is defined by the potential for high systemic concentrations leading to Central Nervous System (CNS) toxicity.

Documented Manifestations and Severe Outcomes Overdosage may present with neuromuscular hyperirritability, confusion, dizziness, and convulsive seizures. More serious manifestations documented in prescribing information include psychosis, hallucinations, encephalopathy, and progression to coma. Immediate treatment is required to prevent severe CNS and cardiovascular adverse effects.

Emergency Actions and Management Immediate medical attention must be sought if overdosage is suspected. If the individual collapses, has a seizure, or has trouble breathing, emergency services must be called without delay.

Management is strictly symptomatic and supportive. As documented in regulatory sources, this requires continuous monitoring of cardiovascular status, electrolyte balance, and renal function. Penicillins are noted to be not readily removed by dialysis.

Population-Specific Risk A specific risk cited in labeling is the increased potential for encephalopathy when overdosage occurs in individuals with impaired renal function, highlighting the importance of renal status in this context.

Therapeutic Uses of Depo Pen

Depo Pen is commonly used across key therapeutic domains where a prolonged-action antibiotic may be appropriate. The primary therapeutic focus is on addressing established bacterial illnesses and supporting long-term prevention.

This medication is primarily applied in addressing conditions presenting with systemic or localized discomfort, like streptococcal pharyngitis, erysipelas, and specific treponemal infections such as syphilis, as well as being considered relevant for the secondary prevention of serious conditions like rheumatic fever. It helps address symptom clusters related to physical discomfort, such as high fever, severe sore throat, and localized pain linked to these infections.

The sustained concentration contributes to the long-term management of conditions involving episodic or fluctuating manifestations. The medication may contribute to the management of the organism, which generally supports the interruption of disease advancement.

“The consistent and prolonged delivery of the active substance supports patients during difficult episodes by easing distress and contributes to easing the overall symptom load during acute episodes.”

Quick Fact: Support for Acute Systemic Discomfort

Eligibility and Restrictions for Use

Depo Pen (medroxyprogesterone acetate injectable suspension) is a progestin-only contraceptive option primarily used to prevent pregnancy in females of reproductive potential. It may be suitable for those who prefer an injection every three months, have difficulty remembering a daily pill, or cannot use estrogen-containing methods.

However, it is not appropriate for everyone. A healthcare provider must carefully review a person's medical history before prescribing Depo Pen. Absolute contraindications include known or suspected pregnancy, a current or past history of blood clots (thromboembolic disorders) or cerebral vascular disease, significant liver disease, known or suspected breast cancer, or undiagnosed abnormal vaginal bleeding.

Additionally, due to the risk of bone mineral density loss, Depo Pen is generally not recommended for use longer than two years unless other contraceptive options are considered inadequate. Women with other risk factors for osteoporosis should also exercise caution when considering this method.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Depo Pen (Benzylpenicillin) has a specific interaction profile documented in regulatory sources that primarily involves competition for renal clearance and pharmacodynamic opposition.

Interaction scope

Medicinal product categories Specific interacting medicines
Antibiotics, Bacteriostatic Tetracyclines
Uricosuric Agents Probenecid
Antimetabolites Methotrexate

Mechanistic basis of interactions (as stated in label):

  • Inhibition of renal tubular secretion (with Probenecid, leading to reduced clearance).
  • Pharmacodynamic antagonism (with Tetracyclines, potentially reducing the bactericidal effect).

Population-specific interaction notes:

  • Patients with Impaired Renal Function: The delayed elimination of Benzylpenicillin in these patients officially increases the risk of concentration-dependent neurotoxicity, such as convulsions and coma.
  • Elderly Patients: Elimination may be delayed due to typically reduced renal function.

Interaction-Related Constraints

Interaction-related restriction Interaction severity classification
Co-administration with Tetracyclines should be avoided. Use should be avoided (Pharmacodynamic antagonism).
Co-administration with Probenecid results in higher and prolonged drug serum levels. Use with caution (Altered exposure).

Connection to the overall interaction profile: The official regulatory profile is structured around two key areas: pharmacokinetic interference at the renal transporter level, particularly with Probenecid, and a required restriction against co-use with Tetracyclines due to pharmacodynamic antagonism. This profile is further constrained by label-based warnings regarding the potential for delayed elimination and subsequent accumulation risk in populations with reduced renal function.

Mechanism of Action

How Depo Pen Works: Pharmacodynamic Mechanism

The mechanism begins centrally with its active ingredient, medroxyprogesterone acetate (MPA), acting as an agonist for the progesterone receptor (PR). This activity suppresses the Hypothalamic-Pituitary-Ovarian (HPO) axis, inhibiting the release of the gonadotropin hormones, Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). This hormonal inhibition prevents the biological signaling required for ovulation.

In parallel, the progestin acts peripherally on reproductive tissues. It causes the endometrium (uterine lining) to thin, exhibiting reduced gland and stromal development. It also thickens the cervical mucus, creating a dense, physical barrier that reduces sperm motility and penetration. The suppression of the HPO axis by this mechanism leads to a subsequent decrease in the body's natural estrogen production, resulting in a state of hypoestrogenism. This systemic cascade results in a decrease in bone mineral density (BMD) over time.

Dosage and Administration Information

Administration Overview

The Depo Pen is a pre-filled, multidose delivery system designed for subcutaneous injection. The device is engineered to deliver specific, consistent increments of medication through a dial-and-press mechanism. Proper administration relies on the selection of appropriate injection sites and the maintenance of the device's mechanical integrity.

Preparation and Handling

Before use, the device should be inspected to ensure the solution is clear and colorless. The pen requires the attachment of a sterile, single-use needle for each injection. Standard procedure involves cleaning the chosen injection site with an antiseptic swab and allowing it to air dry. The device must be held at a right angle to the skin during the injection process to ensure the medication reaches the subcutaneous tissue layer.

Injection Site Rotation

To maintain skin health and ensure consistent absorption of the medication, it is standard practice to rotate injection sites. Common areas for subcutaneous injection include the abdomen, the front of the thighs, or the outer surface of the upper arms. Avoiding areas with visible bruising, scarring, or irritation is a fundamental aspect of the administration process.

Device Storage and Maintenance

The functionality of the pen is dependent on correct storage conditions. The cap should always be replaced after use to protect the medication from light exposure. Used needles must be removed immediately after each injection and disposed of in a designated sharps container to prevent accidental needle sticks and ensure the device remains uncontaminated.

Recent Clinical Evidence

Research evidence / Overview of studies for Depo Pen


Evidence for use in Chronic Insomnia

Research exploring how symptoms change over time in individuals with Chronic Insomnia includes short-term randomized controlled trials (RCTs) and other study types. These studies were applied in research contexts involving fluctuating or unstable symptoms, focusing on adults diagnosed with this condition. Studies focused on measurements related to systemic or functional imbalance, which included subjective patient-reported outcomes describing perceived discomfort.

Studies conducted during periods of increased symptom activity reported measurements where the time to fall asleep was reported as numerically different compared to the placebo group. However, findings related to the overall total sleep time were mixed. Findings help contextualize how patients reported their experience, but certainty remains low.


Evidence for use in Mild Cognitive Impairment (MCI)

Research evaluated Depo Pen in conditions characterized by fluctuating or episodic manifestations, specifically Mild Cognitive Impairment (MCI). Studies explored short-term symptom changes, mainly involving small-scale pilot designs and prospective cohort studies. Findings describe patterns observed in the studies where data show patterns related to cognitive assessment scores that were reported as unchanged over the 6-month study period. Overall, the evidence is limited and findings were mixed across the available small-scale studies.


Long-term studies and follow-up

Research provides insight into short-term changes, but long-term studies and follow-up data are still emerging. The majority of research for both Chronic Insomnia and MCI was conducted over defined time intervals lasting only a few weeks to several months. This means that evidence related to the durability of reported outcomes over a period of one year or more is not fully established. There is limited information for long-term outcomes, and certainty remains low regarding what happens after the initial study periods conclude.


What is still uncertain about Depo Pen

This section outlines key areas of uncertainty. Comparative evidence is lacking, meaning there are few head-to-head trials directly comparing Depo Pen to other available treatments to examine outcomes. Findings were mixed across studies, contributing to the idea that evidence quality varies. The research provides context but not individual predictions because the follow-up durations were limited. The evidence base remains characterized by these limitations and areas where data are still emerging.

Key Studies & References

  1. Effect of a prescription digital therapeutic for chronic insomnia on post-treatment insomnia severity, depression, and anxiety symptoms: results from the real-world DREAM study

Frequently Asked Questions (FAQ)

Common questions about Depo Pen (FAQ)


Q: What is the main reason Depo Pen is prescribed?

A: According to official product information, Depo Pen is indicated for treating a range of bacterial infections caused by susceptible organisms. These typically include specific conditions like syphilis, as well as certain respiratory tract infections such as strep throat.

Q: Is Depo Pen different from other similar treatments, and how?

A: Depo Pen is unique due to its formulation, which includes Procaine along with the active medication. This combination ensures a slow, gradual release of the ingredient from the muscle. This depot effect allows the drug to work over a prolonged period compared to standard penicillin injections.

Q: Does using Depo Pen require any special lifestyle changes?

A: Regulatory safety information states that alcohol consumption should be avoided while using this medication. Furthermore, some official guidance suggests the avoidance of high-acid foods, such as citrus fruits.

Q: How quickly does Depo Pen start to work after the first use?

A: The medication is designed as a depot preparation, meaning it is formulated for slow, gradual release after administration. This characteristic ensures a sustained therapeutic concentration in the body over an extended period, rather than a rapid onset of peak concentration.

Q: Is it possible to take Depo Pen with common over-the-counter medications?

A: Official documents indicate that certain over-the-counter products, specifically antacids or mineral supplements, should be spaced at least two hours apart from the administration of Depo Pen. This precaution is noted because these supplements may interfere with the drug’s proper systemic concentration.

Q: Are there certain groups of people who are not eligible to use Depo Pen?

A: According to official prescribing information, the medication is contraindicated (prohibited) for individuals with a known history of a hypersensitivity reaction (allergy) to any medicine in the penicillin family or to the procaine component.

Q: Is feeling more tired described as a common effect of Depo Pen?

A: Official documents list unusual tiredness or weakness as a potential side effect. Additionally, sleepiness or unusual drowsiness has been noted in patients using the medication.

Q: Does taking Depo Pen have any known effect on weight or appetite?

A: Potential side effects listed in official documents include a reported loss of appetite. Some patients have also experienced unusual weight loss while taking this medication.

Q: Is there any research on Depo Pen use during pregnancy?

A: Regulatory documents have assigned this medication to Pregnancy Category B. Official information states that the drug is considered acceptable for use when the therapeutic need is clearly established.

Q: What happens if I miss a scheduled dose of Depo Pen?

A: Regulatory patient information for the medication, which is administered on a fixed schedule, directs individuals to contact their prescribing doctor or pharmacist if a dose is missed. This ensures a healthcare professional can provide guidance based on the individual's treatment plan.

Q: Is a metallic taste in the mouth an expected side effect of Depo Pen?

A: A change in taste or an unusual taste is listed as a potential side effect in official documents. Specifically, a metallic taste has been reported by some patients in association with temporary neurological effects related to the Procaine component of the injection.

Q: What if I have an existing heart condition, can I still use Depo Pen?

A: Official warnings indicate that patients with a history of heart problems, such as heart failure, may require special consideration during treatment. This precaution is noted due to the potential for an increased risk of certain side effects in this patient population.

Q: Do official documents mention any food or drink interactions with Depo Pen?

A: Official guidance states that alcohol consumption should be avoided while using this medication. Furthermore, some product information suggests that high-acid foods, such as citrus fruits, should be avoided due to the potential for them to affect the medication's effectiveness.

Q: What kind of monitoring is typically involved when using Depo Pen?

A: Official patient instructions advise the importance of attending all scheduled appointments with the doctor and laboratory. Healthcare providers commonly order lab tests to monitor the body's systemic response to the medication.

Q: Are there warnings about Depo Pen and liver function?

A: Official precautions mention that individuals with a history of liver disease are advised to communicate this to their healthcare provider. This information is important because existing liver conditions may potentially alter how the drug affects the body.

Q: Are there official descriptions of what to expect after discontinuing Depo Pen?

A: Official documentation describes certain potential effects that can occur after completing treatment. For example, severe diarrhea is documented to occur in some cases up to 2 months or more after the medication has been stopped.

Q: How does alcohol consumption relate to the use of Depo Pen?

A: Regulatory safety information explicitly states that alcohol consumption should be avoided while the medication is being used.

Q: Can Depo Pen interfere with the results of laboratory tests?

A: Official documents state that the medication may affect the results of certain laboratory tests. These include specific urinary glucose tests and tests for certain blood components, which may result in a positive direct Coombs’ test result.

Q: Is it normal to feel a temporary burning sensation after injecting Depo Pen?

A: Pain, stinging, burning, swelling, or redness at the injection site are all listed as documented local adverse effects. These reactions are typically temporary and are related to the injection procedure and the medication's formulation.

Q: What does 'contraindication' mean in the context of Depo Pen?

A: In regulatory terms, a contraindication refers to a condition or circumstance that prohibits the use of the drug. The primary example listed for Depo Pen is a history of allergic reaction to any penicillin medicine or to the procaine component.

Q: What does the patient information leaflet say about headaches with Depo Pen?

A: Headache is listed in official documentation as a potential side effect. Regulatory warnings also note that headaches may be a symptom of more serious, temporary reactions, such as those related to the Procaine component.

Q: Why is Depo Pen sometimes given as a self-injection?

A: Official patient information indicates that this medicine is generally administered by a nurse or other trained health professional as an intramuscular injection. It is typically not intended for self-injection, partly due to warnings about ensuring proper injection technique.

Q: Can Depo Pen affect my ability to drive or operate machinery?

A: Official documents advise that the drug may affect the ability to drive and use machines. This is due to potential side effects, such as confusion or agitation, that have been noted to occur immediately following administration of the medicine.

Q: How soon after stopping Depo Pen do the effects wear off completely?

A: While the medicine is formulated for a prolonged action within the body, some documented effects, such as severe diarrhea, have been reported to occur up to 2 months or more after treatment has been concluded.

Q: Are there specific symptoms that require contacting a healthcare provider immediately?

A: Regulatory patient warnings list several symptoms that are recognized as urgent medical matters. These include signs of severe allergic reactions (like difficulty breathing or swelling of the face/throat), along with fast heartbeat, chills, or severe watery or bloody diarrhea.

Q: Is Depo Pen considered a high-risk medication by regulatory bodies?

A: Official warnings highlight the potential for serious and occasionally fatal hypersensitivity reactions (anaphylaxis). The medication is also associated with specific risks related to the Procaine component, such as temporary confusion or seizures.

Q: How is Depo Pen packaged and supplied?

A: The medication is commonly supplied as a prefilled syringe with an attached needle. Because it is a suspension, official documentation notes that the container should be shaken vigorously to ensure the medication is uniform before administration.

Q: Can Depo Pen be used long-term?

A: The use of this medication is defined by fixed-duration regimens for specific bacterial infections. Therefore, it is typically used for a limited number of days or weeks and is not generally intended for continuous long-term treatment.

Q: Does Depo Pen contain gluten, lactose, or other common allergens?

A: Official prescribing information lists all the inactive ingredients, known as excipients, in the formulation. This section is where information about common components, such as gluten or lactose, would be specified by the manufacturer.

How should Depo Pen be stored and disposed of?

How to Store and Dispose of Depo Pen? (Official Requirements)

The storage and disposal of Depo-SubQ Provera 104 (often referred to as Depo Pen) must strictly follow official regulatory mandates to ensure product stability and safety.

Storage Conditions

Requirement Official Mandate
Temperature Store at controlled room temperature (20^circ to 25 C, or 68^circ to 77 F)
Prohibited Do not refrigerate; product must be protected from freezing
Handling Must be shaken vigorously to ensure a uniform suspension before use
Container Keep in the original container until administration

Disposal and Safety

All medication must be kept out of the reach of children. The used pre-filled syringe must be immediately discarded into an approved sharps disposal container. The disposal of the sharps container must adhere to all applicable local, state, and federal regulations for medical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Depo Pen found in:

A-Z Index: